Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Seminoma × Carboplatin × Clear all

Phase

Status

Completed 4 Active not recruiting 3 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 89 Lung Neoplasms 40 Ovarian Neoplasms 39 Breast Neoplasms 30 Small Cell Lung Carcinoma 19 Neoplasms 18 Fallopian Tube Neoplasms 14 Carcinoma, Ovarian Epithelial 13 Triple Negative Breast Neoplasms 11 Adenocarcinoma of Lung 10 Neoplasm Metastasis 9 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma 7 Squamous Cell Carcinoma of Head and Neck 6 Lymphoma, Non-Hodgkin 6 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Carcinoma 6 Brain Neoplasms 6 Uterine Cervical Neoplasms 5 Prostatic Neoplasms 5 Adenocarcinoma Of Esophagus 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 4 Neoplasms by Site 4 Neoplasms by Histologic Type 4 Lymphoma, B-Cell 4 Lung Diseases 4

Interventions

Vinblastine 1 Paclitaxel 1 Imatinib Mesylate 1 Ifosfamide 1 Cisplatin 1 Carboplatin 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01593241 2025-02-13

Therapy De-escalation in Seminoma Stage IIA/B

Swiss Cancer Institute

Phase 2 Terminated

Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡